Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3831 | 1899 | 49.5 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
268 | 3 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 44049 |
1384 | 2 | GDNF//GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR//NEURAL TRANSPLANTATION | 8143 |
3831 | 1 | GDNF//GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR//NEURTURIN | 1899 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GDNF | authKW | 2763504 | 22% | 42% | 414 |
2 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR | authKW | 2009528 | 13% | 50% | 249 |
3 | NEURTURIN | authKW | 1025392 | 5% | 71% | 90 |
4 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR GDNF | authKW | 467282 | 2% | 62% | 47 |
5 | GFR ALPHA 1 | authKW | 415770 | 2% | 63% | 41 |
6 | GFR ALPHA | authKW | 342991 | 1% | 89% | 24 |
7 | NEUROTROPHIC FACTORS | authKW | 324097 | 11% | 10% | 201 |
8 | ARTEMIN | authKW | 255747 | 2% | 45% | 35 |
9 | RET | authKW | 236917 | 5% | 15% | 96 |
10 | PERSEPHIN | authKW | 205791 | 1% | 80% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 22483 | 62% | 0% | 1185 |
2 | Medicine, Research & Experimental | 527 | 7% | 0% | 139 |
3 | Clinical Neurology | 432 | 8% | 0% | 153 |
4 | Cell & Tissue Engineering | 307 | 1% | 0% | 24 |
5 | Cell Biology | 279 | 8% | 0% | 156 |
6 | Developmental Biology | 276 | 3% | 0% | 53 |
7 | Biochemistry & Molecular Biology | 267 | 14% | 0% | 272 |
8 | Genetics & Heredity | 159 | 5% | 0% | 100 |
9 | Anatomy & Morphology | 107 | 1% | 0% | 23 |
10 | Biotechnology & Applied Microbiology | 101 | 5% | 0% | 88 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROGRAM MOL NEUROBIOL | 124009 | 1% | 43% | 18 |
2 | GENES MOTOR SYST | 77805 | 1% | 44% | 11 |
3 | BIOMIMET CONTROL PROGRAM | 65646 | 0% | 58% | 7 |
4 | PHARMACEUTNANOBIOCEL GRP | 64312 | 0% | 100% | 4 |
5 | VIIKKI BIO | 51959 | 2% | 8% | 39 |
6 | BRAINS UNIT | 42872 | 0% | 67% | 4 |
7 | MOL IMAGING NEUROSCI | 36535 | 0% | 45% | 5 |
8 | AFFILIATED WUTAISHAN HOSP | 33490 | 0% | 42% | 5 |
9 | WALLENBERG NEUROSCI | 32308 | 2% | 5% | 38 |
10 | ASSAY DEV TARGET VALIDAT | 32156 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL NEUROLOGY | 25667 | 6% | 1% | 122 |
2 | NEUROBIOLOGY OF DISEASE | 6625 | 2% | 1% | 39 |
3 | MOLECULAR AND CELLULAR NEUROSCIENCE | 4160 | 1% | 1% | 27 |
4 | NEUROREPORT | 3691 | 3% | 0% | 52 |
5 | JOURNAL OF NEUROSCIENCE | 3404 | 5% | 0% | 86 |
6 | EUROPEAN JOURNAL OF NEUROSCIENCE | 3015 | 2% | 0% | 46 |
7 | BRAIN RESEARCH | 2567 | 5% | 0% | 89 |
8 | JOURNAL OF NEUROSCIENCE RESEARCH | 2454 | 2% | 0% | 37 |
9 | NEUROSCIENCE | 2381 | 3% | 0% | 58 |
10 | MOLECULAR BRAIN RESEARCH | 2368 | 1% | 1% | 26 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GDNF | 2763504 | 22% | 42% | 414 | Search GDNF | Search GDNF |
2 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR | 2009528 | 13% | 50% | 249 | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR |
3 | NEURTURIN | 1025392 | 5% | 71% | 90 | Search NEURTURIN | Search NEURTURIN |
4 | GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR GDNF | 467282 | 2% | 62% | 47 | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR+GDNF | Search GLIAL+CELL+LINE+DERIVED+NEUROTROPHIC+FACTOR+GDNF |
5 | GFR ALPHA 1 | 415770 | 2% | 63% | 41 | Search GFR+ALPHA+1 | Search GFR+ALPHA+1 |
6 | GFR ALPHA | 342991 | 1% | 89% | 24 | Search GFR+ALPHA | Search GFR+ALPHA |
7 | NEUROTROPHIC FACTORS | 324097 | 11% | 10% | 201 | Search NEUROTROPHIC+FACTORS | Search NEUROTROPHIC+FACTORS |
8 | ARTEMIN | 255747 | 2% | 45% | 35 | Search ARTEMIN | Search ARTEMIN |
9 | RET | 236917 | 5% | 15% | 96 | Search RET | Search RET |
10 | PERSEPHIN | 205791 | 1% | 80% | 16 | Search PERSEPHIN | Search PERSEPHIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | IBANEZ, CF , ANDRESSOO, JE , (2017) BIOLOGY OF GDNF AND ITS RECEPTORS - RELEVANCE FOR DISORDERS OF THE CENTRAL NERVOUS SYSTEM.NEUROBIOLOGY OF DISEASE. VOL. 97. ISSUE . P. 80 -89 | 90 | 64% | 3 |
2 | SULLIVAN, AM , TOULOUSE, A , (2011) NEUROTROPHIC FACTORS FOR THE TREATMENT OF PARKINSON'S DISEASE.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 22. ISSUE 3. P. 157-165 | 115 | 86% | 24 |
3 | KELLY, MJ , O'KEEFFE, GW , SULLIVAN, AM , (2015) VIRAL VECTOR DELIVERY OF NEUROTROPHIC FACTORS FOR PARKINSON'S DISEASE THERAPY.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 17. ISSUE . P. - | 96 | 77% | 3 |
4 | QUARTU, M , SERRA, MP , BOI, M , FERRETTI, MT , LAI, ML , DEL FIACCO, M , (2007) TISSUE DISTRIBUTION OF RET, GFRALPHA-1, GFRALPHA-2 AND GFRALPHA-3 RECEPTORS IN THE HUMAN BRAINSTEM AT FETAL, NEONATAL AND ADULT AGE.BRAIN RESEARCH. VOL. 1173. ISSUE . P. 36-52 | 101 | 81% | 11 |
5 | BJORKLUND, A , CENCI, MA , (2010) NEUROTROPHIC FACTOR THERAPY FOR PARKINSON'S DISEASE.RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH. VOL. 184. ISSUE . P. 237 -264 | 124 | 62% | 0 |
6 | DE TASSIGNY, XD , PASCUAL, A , LOPEZ-BARNEO, J , (2015) GDNF-BASED THERAPIES, GDNF-PRODUCING INTERNEURONS, AND TROPHIC SUPPORT OF THE DOPAMINERGIC NIGROSTRIATAL PATHWAY. IMPLICATIONS FOR PARKINSON'S DISEASE.FRONTIERS IN NEUROANATOMY. VOL. 9. ISSUE . P. - | 87 | 61% | 8 |
7 | KORDOWER, JH , BJORKLUND, A , (2013) TROPHIC FACTOR GENE THERAPY FOR PARKINSON'S DISEASE.MOVEMENT DISORDERS. VOL. 28. ISSUE 1. P. 96-109 | 60 | 78% | 46 |
8 | KRAMER, ER , LISS, B , (2015) GDNF-RET SIGNALING IN MIDBRAIN DOPAMINERGIC NEURONS AND ITS IMPLICATION FOR PARKINSON DISEASE.FEBS LETTERS. VOL. 589. ISSUE 24. P. 3760 -3772 | 102 | 50% | 5 |
9 | DUARTE, EP , SAAVEDRA, A , BALTAZAR, G , (2008) DRIVING GDNF EXPRESSION: THE GREEN AND THE RED TRAFFIC LIGHTS.PROGRESS IN NEUROBIOLOGY. VOL. 86. ISSUE 3. P. 186 -215 | 154 | 36% | 48 |
10 | CARNICELLA, S , RON, D , (2009) GDNF - A POTENTIAL TARGET TO TREAT ADDICTION.PHARMACOLOGY & THERAPEUTICS. VOL. 122. ISSUE 1. P. 9 -18 | 84 | 60% | 34 |
Classes with closest relation at Level 1 |